167 related articles for article (PubMed ID: 30074510)
1. Advances in the early diagnosis and therapy of inclusion body myositis.
Lilleker JB
Curr Opin Rheumatol; 2018 Nov; 30(6):644-649. PubMed ID: 30074510
[TBL] [Abstract][Full Text] [Related]
2. Inclusion body myositis: advancements in diagnosis, pathomechanisms, and treatment.
Schmidt K; Schmidt J
Curr Opin Rheumatol; 2017 Nov; 29(6):632-638. PubMed ID: 28832349
[TBL] [Abstract][Full Text] [Related]
3. Inclusion Body Myositis.
Goyal NA
Continuum (Minneap Minn); 2022 Dec; 28(6):1663-1677. PubMed ID: 36537974
[TBL] [Abstract][Full Text] [Related]
4. Inclusion body myositis: update.
Lahouti AH; Amato AA; Christopher-Stine L
Curr Opin Rheumatol; 2014 Nov; 26(6):690-6. PubMed ID: 25215417
[TBL] [Abstract][Full Text] [Related]
5. Update in inclusion body myositis.
Machado P; Brady S; Hanna MG
Curr Opin Rheumatol; 2013 Nov; 25(6):763-71. PubMed ID: 24067381
[TBL] [Abstract][Full Text] [Related]
6. Cytosolic 5'-nucleotidase 1A autoimmunity in sporadic inclusion body myositis.
Larman HB; Salajegheh M; Nazareno R; Lam T; Sauld J; Steen H; Kong SW; Pinkus JL; Amato AA; Elledge SJ; Greenberg SA
Ann Neurol; 2013 Mar; 73(3):408-18. PubMed ID: 23596012
[TBL] [Abstract][Full Text] [Related]
7. Sporadic inclusion body myositis: new insights and potential therapy.
Machado PM; Dimachkie MM; Barohn RJ
Curr Opin Neurol; 2014 Oct; 27(5):591-8. PubMed ID: 25159931
[TBL] [Abstract][Full Text] [Related]
8. Ongoing developments in sporadic inclusion body myositis.
Machado PM; Ahmed M; Brady S; Gang Q; Healy E; Morrow JM; Wallace AC; Dewar L; Ramdharry G; Parton M; Holton JL; Houlden H; Greensmith L; Hanna MG
Curr Rheumatol Rep; 2014 Dec; 16(12):477. PubMed ID: 25399751
[TBL] [Abstract][Full Text] [Related]
9. Biomarkers of inclusion body myositis.
Greenberg SA
Curr Opin Rheumatol; 2013 Nov; 25(6):753-62. PubMed ID: 24067380
[TBL] [Abstract][Full Text] [Related]
10. [Pathogenesis of inclusion body myositis: autoimmune or degenerative disease?].
Uruha A; Nishino I
Brain Nerve; 2013 Nov; 65(11):1291-8. PubMed ID: 24200607
[TBL] [Abstract][Full Text] [Related]
11. Sensitivity and clinical utility of the anti-cytosolic 5'-nucleotidase 1A (cN1A) antibody test in sporadic inclusion body myositis: Report of 40 patients from a single neuromuscular center.
Felice KJ; Whitaker CH; Wu Q; Larose DT; Shen G; Metzger AL; Barton RW
Neuromuscul Disord; 2018 Aug; 28(8):660-664. PubMed ID: 30001928
[TBL] [Abstract][Full Text] [Related]
12. Magnetic resonance imaging pattern recognition in sporadic inclusion-body myositis.
Tasca G; Monforte M; De Fino C; Kley RA; Ricci E; Mirabella M
Muscle Nerve; 2015 Dec; 52(6):956-62. PubMed ID: 25808807
[TBL] [Abstract][Full Text] [Related]
13. Cytosolic 5'-nucleotidase 1A autoantibody profile and clinical characteristics in inclusion body myositis.
Lilleker JB; Rietveld A; Pye SR; Mariampillai K; Benveniste O; Peeters MT; Miller JA; Hanna MG; Machado PM; Parton MJ; Gheorghe KR; Badrising UA; Lundberg IE; Sacconi S; Herbert MK; McHugh NJ; Lecky BR; Brierley C; Hilton-Jones D; Lamb JA; Roberts ME; Cooper RG; Saris CG; Pruijn GJ; Chinoy H; van Engelen BG;
Ann Rheum Dis; 2017 May; 76(5):862-868. PubMed ID: 28122761
[TBL] [Abstract][Full Text] [Related]
14. [Sporadic Inclusion Body Myositis and Autoantibodies].
Yamashita S; Ando Y
Brain Nerve; 2018 Apr; 70(4):449-457. PubMed ID: 29632292
[TBL] [Abstract][Full Text] [Related]
15. Inclusion Body Myositis.
Greenberg SA
Continuum (Minneap Minn); 2016 Dec; 22(6, Muscle and Neuromuscular Junction Disorders):1871-1888. PubMed ID: 27922498
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic and prognostic value of anti-cN1A antibodies in inclusion body myositis.
Salam S; Dimachkie MM; Hanna MG; Machado PM
Clin Exp Rheumatol; 2022 Feb; 40(2):384-393. PubMed ID: 35225226
[TBL] [Abstract][Full Text] [Related]
17. Inclusion body myositis: a review of clinical and genetic aspects, diagnostic criteria and therapeutic approaches.
Mastaglia FL; Needham M
J Clin Neurosci; 2015 Jan; 22(1):6-13. PubMed ID: 25510538
[TBL] [Abstract][Full Text] [Related]
18. Clinical and serological characteristics of 125 Dutch myositis patients. Myositis specific autoantibodies aid in the differential diagnosis of the idiopathic inflammatory myopathies.
Hengstman GJ; Brouwer R; Egberts WT; Seelig HP; Jongen PJ; van Venrooij WJ; van Engelen BG
J Neurol; 2002 Jan; 249(1):69-75. PubMed ID: 11954871
[TBL] [Abstract][Full Text] [Related]
19. [Inclusion body myositis pathomechanism and therapy].
Váncsa A; Dankó K
Orv Hetil; 2008 Jul; 149(30):1413-8. PubMed ID: 18621600
[TBL] [Abstract][Full Text] [Related]
20. Sporadic inclusion body myositis misdiagnosed as idiopathic granulomatous myositis.
Lavian M; Goyal N; Mozaffar T
Neuromuscul Disord; 2016 Nov; 26(11):741-743. PubMed ID: 27692540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
